Since the beginning of recorded history, the hemp or Cannabis sativa plant has been used in traditional medicine and religious ceremonies.
The Native Americans used the plant as a stimulant to promote recovery from a number of diseases and ailments. In the last couple of decades, about 150 cannabinoids have been identified with thousands of publications characterizing the chemistry, biology, and pharmacology with a large share focusing on CBD's benefits.
While the FDA has not yet approved CBD and related cannabinoids for the control of pain and inflammation, there have been numerous preclinical and clinical studies to help understand CBD's potential to control certain types of pain. A growing volume of data in animal and human clinical trials suggests CBD may be effective as an anti-inflammatory agent to combat diseases such as Osteoarthritis.
Sycamore BioPharma uses Super-Critical CO2 processing to extract CBD and other beneficial cannabinoids from the Cannabis Sativa plant. It is simply the cleanest and safest method for removing organic small molecules from botanical biomass, leaving only trace amounts of benign CO2 instead of butane or ethanol used by other extraction methods.